anti-CD146-ts

anti-CD146-ts is an experimental **monoclonal antibody** directed against a **tumor-specific form of CD146**, also known as melanoma cell adhesion molecule. The program appears to have originated from work at Aix-Marseille Université and associated French academic investigators, with sublicensed immunoconjugate development rights transferred by SATT Sud-Est to Syndivia. It is being positioned as a first-in-class oncology targeting approach for solid tumors, particularly **melanoma** and **pancreatic cancer**, based on reported tumor-specific expression of the CD146-ts epitope and its proposed role in tumorigenesis. Publicly available information indicates a **preclinical** development stage, and the exact final therapeutic format, payload configuration, and clinical formulation have not been clearly disclosed.

Other names

anti-CD146-ts antibodyanti-CD-146-ts antibodyanti-CD 146-ts antibodyanti-CD146-ts immunoconjugateanti-CD-146-ts immunoconjugateanti-CD 146-ts immunoconjugateCD146-ts monoclonal antibodyCD-146-ts monoclonal antibodyCD 146-ts monoclonal antibody